Literature DB >> 1471918

Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report.

M Klein1, O Krieger, R Ruckser, A Rosen, R Waldner, P Preis, A Beck.   

Abstract

The gender-specific prevalence of lymphangioleiomyomatosis (LAM) in premenopausal women suggests a hormonal etiology. Despite the antiestrogenic treatment (ovariectomy, tamoxifen) this disease is often refractory to therapy and almost inevitably leads to the patient's death. We describe a case where the antiproliferative effect of systemically applied interferon alpha 2b was successfully employed in addition to ovariectomy and the patient reached complete remission.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1471918     DOI： 10.1007/bf02389635

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  15 in total

1.  Lymphangioleiomyomatosis. Clinical course in 32 patients.

Authors:  J R Taylor; J Ryu; T V Colby; T A Raffin
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

2.  Pulmonary lymphangiomyomatosis. A review.

Authors:  B Corrin; A A Liebow; P J Friedman
Journal:  Am J Pathol       Date:  1975-05       Impact factor: 4.307

3.  Interferon alpha in the therapy of CML.

Authors:  M Talpaz; H Kantarjian; R Kurzrock; J U Gutterman
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

4.  Treatment of haemangioendotheliomas with alpha interferon.

Authors:  P J Orchard; C M Smith; W G Woods; D L Day; L P Dehner; R Shapiro
Journal:  Lancet       Date:  1989-09-02       Impact factor: 79.321

Review 5.  Treatment of hemangiomatosis with recombinant interferon alfa.

Authors:  C W White
Journal:  Semin Hematol       Date:  1990-07       Impact factor: 3.851

6.  Pulmonary lymphangiomyomatosis. Long-term survival in a patient with poor response to medroxyprogesterone.

Authors:  F A Bevelaqua; H Epstein
Journal:  Chest       Date:  1985-04       Impact factor: 9.410

7.  Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma.

Authors:  A S Banner; C B Carrington; W B Emory; F Kittle; G Leonard; J Ringus; P Taylor; W W Addington
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

8.  Pulmonary lymphangiomyomatosis responsive to progesterone.

Authors:  K S McCarty; J A Mossler; R McLelland; H O Sieker
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

9.  Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases.

Authors:  D C Rappaport; G L Weisbrod; S J Herman; D W Chamberlain
Journal:  AJR Am J Roentgenol       Date:  1989-05       Impact factor: 3.959

10.  Pulmonary lymphangiomyomatosis.

Authors:  W Dishner; E M Cordasco; J Blackburn; S Demeter; H Levin; W D Carey
Journal:  Chest       Date:  1984-06       Impact factor: 9.410
View more
  5 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Lymphangioleiomyomatosis, chylous ascites, and diet.

Authors:  E Calvo; L Amarillas; M A Mateos; J L Orradre; G Gilsanz; J L Alvarez-Sala; D Espinos
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

3.  High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.

Authors:  S M Chang; F G Barker; S L Huhn; M K Nicholas; M Page; J Rabbitt; M D Prados
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

4.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

5.  Lymphangiomyomatosis discovered by massive hemoptysis during general anesthesia -A case report-.

Authors:  Deokkyu Kim; Sung Nyu Lee; Sang-Kyi Lee; Jeongwoo Lee
Journal:  Korean J Anesthesiol       Date:  2012-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.